Genprex, Inc. (@genprex) header
Genprex, Inc. (@genprex) profile picture

Genprex (Nasdaq: $GNPX) is a clinical-stage gene therapy company focused on developing life-changing technologies for patients with cancer and diabetes.

Austin, TX
Joined July 2016
Photo by Genprex, Inc. (@genprex)Photo by Genprex, Inc. (@genprex)Photo by Genprex, Inc. (@genprex)Photo by Genprex, Inc. (@genprex)Photo by Genprex, Inc. (@genprex)Photo by Genprex, Inc. (@genprex)Photo by Genprex, Inc. (@genprex)Photo by Genprex, Inc. (@genprex)Photo by Genprex, Inc. (@genprex)Photo by Genprex, Inc. (@genprex)
Genprex Presents Preclinical Data Identifying TROP2 as a Potential Predictive Biomarker for Reqorsa® Gene Therapy in Lung Cancer: genprex.com/2026/11/19/genpr… #Biomarkers #LungCancer
1
4
133
Watch our new video, "Dual Delivery Strategies for Diabetes Gene Therapy," where $GNPX Senior Director of Quality Control & Product Development, Pier-Anne Lachance, Ph.D presents lessons from parallel AAV and lipid-based development programs: genprex.com/videos/#Diabetes #GeneTherapy
1
1
145
Genprex to Highlight Dual Delivery Strategy for Diabetes Gene Therapy at Future of Cell and Gene Therapy Symposium: ow.ly/4KvK5105MGl #GeneTherapy #Diabetes
1
2
149
Genprex executives are in Cologne at #BioEurope, connecting with biotech leaders, sharing updates on our programs and exploring opportunities to build new partnerships or collaborations.
1
3
162
Genprex Presents Data Showing Reqorsa® Gene Therapy Activates Cellular Repair and Maintenance Programs Linked to Aging Biology in Patients, Supporting TUSC2 as a Key Regulator of Resilience to Aging-Associated Stress: genprex.com/2026/11/05/genpr… $GNPX
1
1
163
Genprex Announces New Research Identifying TROP2 as a Potential Predictive Biomarker to Reqorsa® Gene Therapy in Lung Cancer: genprex.com/2026/11/04/genpr… #LungCancer $GNPX
2
146
Genprex Highlights New Preclinical Data Identifying Role of TUSC2, the Gene Used in REQORSA®, in Maintaining Cellular Function During Brain Aging: ow.ly/KBsY50ZZGQ3 #Aging
3
519
Genprex to Present at the H.C. Wainwright 28th Annual Global Investment Conference: ow.ly/iM7q50ZKCLi #GeneTherapy #LungCancer #Diabetes
1
4
229
$GNPX has treated 100+ patients with Reqorsa® throughout its various clinical trials. While other cancer treatments can cause harsh side effects and have long-term effects, we believe in REQORSA’s high degree of patient safety and tolerability #LungCancer
1
4
283
Genprex Selects Leading Clinical and Commercial Contract Development and Manufacturing Organization for Manufacturing Scale Up of Diabetes Gene Therapy: ow.ly/X8cq50ZATey #Diabetes #GeneTherapy
4
302
Genprex Announces Collaboration with Roche Diagnostics for Biomarker Assay Validation Studies: ow.ly/YY5m50ZvMn7 #LungCancer
3
9
626
Genprex Receives a Notice of Allowance from The Canadian Intellectual Property Office for a Patent Claiming the Combination of Reqorsa® Gene Therapy with Either PD-1 or PD-L1 Antibodies to Treat Cancer: ow.ly/9Bj150ZfcY9 #LungCancer #GeneTherapy
1
1
2
289
Genprex to Participate at BIO International Convention 2026: ow.ly/WLjg50ZcIk6 #BIO2026 #GeneTherapy #LungCancer #Diabetes
1
114
A few members from the Genprex team attended #ASCO2026 this week where our collaborators' abstract was published detailing positive clinical data from studies of predictive biomarkers in patients receiving Reqorsa® for the treatment of #lungcancer.
3
225
Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa® Gene Therapy Published at the 2026 ASCO Annual Meeting: ow.ly/mlEW50Z4bQs #ASCO #LungCancer
4
176
Our research collaborators presented positive preclinical data on our diabetes gene therapy at the 2026 ASGCT Annual Meeting. The poster can be reviewed in detail by clicking here: ow.ly/5to850Z0ee2 #Diabetes #Type2 #GeneTherapy
4
168
Genprex Collaborators Present Positive Preclinical Data on Diabetes Gene Therapy for Type 2 Diabetes at the 2026 American Society of Gene and Cell Therapy Annual Meeting: ow.ly/uQlx50YZtGn #GeneTherapy #Diabetes
3
224
Genprex was featured in Cure's Member Spotlight series, where they highlight the groundbreaking work of the companies and individuals in Cure’s community. Check out the Q&A with Genprex's President and CEO here: ow.ly/ByIR50YZ0Ns #GeneTherapy #LungCancer #Diabetes
1
3
5
284
Genprex Receives Patent Grant from The Israel Patent Office for the Combination of Reqorsa® Gene Therapy and PD-1 Antibodies to Treat Cancer: ow.ly/irx250YSoy9 #GeneTherapy #LungCancer
1
4
315